Targeting of vasculature in cancer and other angiogenic diseases

Trends Immunol. 2001 Mar;22(3):129. doi: 10.1016/s1471-4906(00)01840-8.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Angiogenesis Inhibitors / therapeutic use*
  • Antibodies, Monoclonal / immunology
  • Antibodies, Monoclonal / therapeutic use*
  • Antigens, CD
  • Arthritis, Rheumatoid / therapy
  • Diabetic Retinopathy / therapy
  • Endoglin
  • Endothelium, Vascular
  • Humans
  • Neoplasms / immunology
  • Neoplasms / therapy*
  • Neovascularization, Pathologic
  • Neurodegenerative Diseases / therapy
  • Psoriasis / therapy
  • Receptors, Cell Surface
  • Receptors, Vitronectin / immunology
  • Scleroderma, Systemic / therapy
  • Thalidomide / therapeutic use
  • Vascular Cell Adhesion Molecule-1 / immunology

Substances

  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal
  • Antigens, CD
  • ENG protein, human
  • Endoglin
  • Receptors, Cell Surface
  • Receptors, Vitronectin
  • Vascular Cell Adhesion Molecule-1
  • Thalidomide